You are here:

caspofungin acetate (Caspofungin)


following a full submission:

caspofungin acetate (Caspofungin) is accepted for restricted use within NHS Scotland.

Caspofungin provides an additional agent for the treatment of invasive candidiasis. Its use should be restricted to patients with fluconazole-resistant Candida infection who do not respond to, or cannot tolerate amphotericin B therapy or who are at an increased risk of serious side effects with amphotericin (eg. transplant patients, especially those receiving bone marrow transplants).

Drug Details

Drug Name: caspofungin acetate (Caspofungin)
SMC Drug ID: 74/03
Manufacturer: MSD
Indication: Invasive candidiasis
BNF Category:
Sub Category: 5.2 Antifungal Drugs
Submission Type: Full submission
Status: Restricted
Date Advice Published: 12 January 2004